EA201891736A1 - Сокристалл - Google Patents

Сокристалл

Info

Publication number
EA201891736A1
EA201891736A1 EA201891736A EA201891736A EA201891736A1 EA 201891736 A1 EA201891736 A1 EA 201891736A1 EA 201891736 A EA201891736 A EA 201891736A EA 201891736 A EA201891736 A EA 201891736A EA 201891736 A1 EA201891736 A1 EA 201891736A1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxo
sokristal
cocrystal
hydroxyacetyl
trifluoroethoxy
Prior art date
Application number
EA201891736A
Other languages
English (en)
Other versions
EA035376B1 (ru
Inventor
Кентаро Ивата
Юкихиро Икеда
Original Assignee
Такеда Фармасьютикал Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютикал Компани Лимитед filed Critical Такеда Фармасьютикал Компани Лимитед
Publication of EA201891736A1 publication Critical patent/EA201891736A1/ru
Publication of EA035376B1 publication Critical patent/EA035376B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В изобретении представлены улучшение растворимости органического соединения и сокристалл (1) 6-этил-N-[1-(гидроксиацетил)пиперидин-4-ил]-1-метил-4-оксо-5-(2-оксо-2-фенилэтил)-3-(2,2,2-трифторэтокси)-4,5-дигидро-1H-пирроло[3,2-c]пиридин-2-карбоксамида и (2) L-яблочной кислоты или L-винной кислоты.
EA201891736A 2016-02-01 2017-01-31 Сокристалл EA035376B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016017099 2016-02-01
PCT/JP2017/003453 WO2017135259A1 (ja) 2016-02-01 2017-01-31 共結晶

Publications (2)

Publication Number Publication Date
EA201891736A1 true EA201891736A1 (ru) 2019-02-28
EA035376B1 EA035376B1 (ru) 2020-06-03

Family

ID=59499867

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891736A EA035376B1 (ru) 2016-02-01 2017-01-31 Сокристалл

Country Status (11)

Country Link
US (2) US10906898B2 (ru)
EP (2) EP3954372A1 (ru)
JP (1) JP6827429B2 (ru)
CN (2) CN113788826A (ru)
CA (1) CA3013183A1 (ru)
DK (1) DK3412667T3 (ru)
EA (1) EA035376B1 (ru)
ES (1) ES2902513T3 (ru)
HU (1) HUE057240T2 (ru)
PT (1) PT3412667T (ru)
WO (1) WO2017135259A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6827429B2 (ja) * 2016-02-01 2021-02-10 武田薬品工業株式会社 共結晶
JP6916969B1 (ja) * 2018-06-21 2021-08-11 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ３−（（１Ｒ，３Ｒ）−１−（２，６−ジフルオロ−４−（（１−（３−フルオロプロピル）アゼチジン−３−イル）アミノ）フェニル）−３−メチル−１，３，４，９−テトラヒドロ−２Ｈ−ピリド［３，４−ｂ］インドール−２−イル）−２，２−ジフルオロプロパン−１−オールの固体形態及び置換されたフェニル又はピリジニル部分を含む縮合三環式化合物を調製するための方法とそれらの使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010009372A (es) * 2008-02-26 2010-09-22 Takeda Pharmaceutical Derivado heterociclico fusionado y su uso.
JP2016017099A (ja) 2014-07-04 2016-02-01 富士フイルム株式会社 新規化合物、染色又は捺染用着色組成物、インクジェット捺染用インク、布帛を捺染する方法、及び染色又は捺染された布帛
JP6827429B2 (ja) * 2016-02-01 2021-02-10 武田薬品工業株式会社 共結晶

Also Published As

Publication number Publication date
US10906898B2 (en) 2021-02-02
EP3412667A1 (en) 2018-12-12
CA3013183A1 (en) 2017-08-10
ES2902513T3 (es) 2022-03-28
CN108884094A (zh) 2018-11-23
EP3954372A1 (en) 2022-02-16
EP3412667B1 (en) 2021-11-03
EP3412667A4 (en) 2019-09-18
US20200048245A1 (en) 2020-02-13
JP6827429B2 (ja) 2021-02-10
PT3412667T (pt) 2022-01-20
CN108884094B (zh) 2021-09-21
JPWO2017135259A1 (ja) 2018-11-22
DK3412667T3 (da) 2022-01-10
HUE057240T2 (hu) 2022-04-28
US20210115039A1 (en) 2021-04-22
WO2017135259A1 (ja) 2017-08-10
CN113788826A (zh) 2021-12-14
EA035376B1 (ru) 2020-06-03

Similar Documents

Publication Publication Date Title
CY1123443T1 (el) Οξεα καρβαμοϋλοξυμεθυλ-τριαζολ-κυκλοεξυλιου ως ανταγωνιστες lpa
CY1120988T1 (el) Παρεμποδιστες διαρυλ κινασης
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
EA202091484A1 (ru) 4-азаиндольные соединения
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
UA117976C2 (uk) Сполуки амінопіримідинілу як інгібітори jak
EA202091508A1 (ru) 6-азаиндольные соединения
EA201792619A1 (ru) Нафтиридиновые соединения в качестве ингибиторов jak киназы
EA201892436A1 (ru) Пиримидиновые соединения в качестве ингибиторов jak киназы
EA202090413A1 (ru) Пиразоло- и триазолобициклические соединения в качестве ингибиторов jak киназы
CY1121746T1 (el) Αναστολεις mgat2 τετραζολονο-υποκατεστημενης διυδροπυριδινονης
EA201790492A1 (ru) СОЕДИНЕНИЯ, КОТОРЫЕ ИНГИБИРУЮТ БЕЛОК Mcl-1
EA201591420A1 (ru) Гетероарильные соединения и их применение
EA201691421A1 (ru) Гетероарилы и их применение
EA201892202A1 (ru) Способы лечения холестатических заболеваний
EA202091477A1 (ru) Замещенные соединения простых индольных эфиров
CL2021000426A1 (es) Inhibidores de la interacción proteína-proteína keap1-nrf2.
MX2018015247A (es) Heterociclos de biarilmetilo.
PH12017500029A1 (en) 4,5-dihydroisoxazole derivatives as nampt inhibitors
CY1123722T1 (el) Ενεσιμα φαρμακευτικα σκευασματα λεφαμουλινης
EA201791140A1 (ru) Противомикробные составы и соответствующие методы обработки пищевых продуктов и поверхностей
EA201790594A1 (ru) Противомикробные композиции и способы их применения
EA201691549A1 (ru) Ариллактамные ингибиторы киназы
EA201792262A1 (ru) Пироглутамат вортиоксетина
CY1123406T1 (el) Παραγωγο τριαζολοπυραζινονης χρησιμο ως ενας ανθρωπινος pde1 αναστολεας

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM